Skip to main content
Log in

ICER releases corrected report on NSCLC therapies

  • News item
  • Published:
PharmacoEconomics & Outcomes News

This is a preview of subscription content, log in via an institution to check access.

Access this article

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Notes

  1. PDCD-1 protein inhibitors

  2. CD274 antigen inhibitors

  3. see PharmacoEconomics & Outcomes News 763 p8; 803202007

  4. Comparative Effectiveness Public Advisory Council

Reference

Download references

Rights and permissions

Reprints and permissions

About this article

Check for updates. Verify currency and authenticity via CrossMark

Cite this article

ICER releases corrected report on NSCLC therapies. PharmacoEcon Outcomes News 764, 3 (2016). https://doi.org/10.1007/s40274-016-3452-z

Download citation

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s40274-016-3452-z

Navigation